Browsing Tag
Charles River Laboratories
11 posts
Made Scientific and Syenex team up to reshape T cell therapy manufacturing with advanced bioengineering platforms
Made Scientific and Syenex partner to scale T cell therapy manufacturing with UltraCell and RapidCell systems, aiming to cut costs and speed timelines.
Charles River Laboratories appoints Michael G. Knell as interim CFO as Flavia Pease exits
Charles River Labs appoints Michael Knell interim CFO as Flavia Pease departs. Find out how this move impacts financial guidance and investor sentiment today.
Charles River and Akron Bio collaborate to enhance cell therapy manufacturing
Charles River Laboratories International, Inc. and Akron Bio have unveiled a partnership that is poised to redefine cell…
Charles River, Related Sciences team up for AI-driven drug discovery
Charles River Laboratories International, Inc. (NYSE: CRL) and Related Sciences have announced a multi-program collaboration valued at an…
Immutep taps Charles River for IMP761 LAG-3 antibody preclinical study
Immutep Limited, an Australian biotech company specializing in LAG-3 immunotherapies for cancer and autoimmune diseases, has partnered with…
Pisgah Ridge Solar project : Duke Energy begins operations at Navarro County facility
Duke Energy has commenced operations at the 250MW Pisgah Ridge Solar project in Navarro County, Texas, which is…
Arlington Capital Partners acquires AVS Bio from Charles River Laboratories
Arlington Capital Partners, a US-based private equity firm, has acquired Avian Vaccine Services business from Charles River Laboratories.…
Pisgah Ridge Solar project : Duke Energy breaks ground on 250MW solar power plant
Duke Energy Sustainable Solutions, a commercial brand of Duke Energy, has broken ground on the 250MW Pisgah Ridge…
Charles River Laboratories to acquire gene therapy CDMO Vigene Biosciences
Charles River Laboratories International has signed an all-cash deal worth $292.5 million to acquire Vigene Biosciences, a US-based…
HemaCare to be acquired by Charles River Laboratories for $380m
Charles River acquisition of HemaCare : Charles River Laboratories International, an early-stage contract research organization, has agreed to…